Pharmaceutical preparation based on Lys-plasminogen
US5304383A · kind A · utility
29Cited by
0References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 8, 1991 |
| Grant date | Apr 19, 1994 |
| Priority date | — |
| Expiry date | Oct 8, 2011 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/831
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
There is disclosed a pharmaceutical preparation based on Lys-plasminogen and available in the lyophilized form. This preparation contains a serine-protease inhibitor and optionally an inhibitor co-factor, preferably in an amount of 0.5 to 30 nmol per mg Lys-plasminogen. This preparation is free of side-effects and may be used for the treatment and prophylaxis of plasminogen deficiency syndromes and thromboses as well as for the production of thromboresistant artificial organs.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.